Category : Weekly Snapshot

Pfizer’s Vizimpro (Dacomitinib) Receives the US FDA Approval for 1L Treatment of mNSCLC with Epidermal Growth Factor Receptor (EGFR) Published: 27 Sep, 2018 |Tags: Pfizer, Vizimpro, Receives, the US FDA […]readmore

Merck’s Delstrigo and Pifeltro Receives CHMP Approval for the Treatment of HIV-1 Infection in EU Published: 20 Sep, 2018 |Tags: Merck, Delstrigo, Pifeltro, Receives, CHMP Approval, Treatment, HIV-1 Infection, EU, […]readmore

Genentech Receives FDA approval for Actemra SC for the Treatment of Active Systemic JIA in patients aged ≥2 yrs. Published: 13 Sept, 2018 |Tags: Genentech, Receives, FDA, approval, Actemra SC, […]readmore

Mylan Discloses its Previous Acquisition of Worldwide Rights to Commercialize Novartis’ Products for $463M Published- 5 Sept, 2018 |Tags: Mylan, Discloses, Acquisition, Worldwide, Rights, Novartis, $463M BeiGene and SpringWorks Globally […]readmore

Pfizer Terminates Domagrozumab trial for the treatment of Duchenne muscular dystrophy Published: 30 Aug,2018 |Tags: Pfizer, Terminates, Domagrozumab, Treatment, DMD MedImmune (AZ) reports results of TULIP 1 P-III for anifrolumab […]readmore

Eisai’s and Merck Announces EU’s Marketing Approval of Lenvima (lenvatinib mesylate) for Hepatocellular Carcinoma Published: 23 Aug,2018 | Tags: Eisai, Merck, Approval, Lenvima, HCC, Novartis’s Solar-1 trial BYL719 (PI3Ki, alpelisib) […]readmore